OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prostate Cancer: Genetics, Epigenetics and the Need for Immunological Biomarkers
Guzel Rafikova, I. R. Gilyazova, Kadriia Enikeeva, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12797-12797
Open Access | Times Cited: 16

Showing 16 citing articles:

The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway
Vasiliki Zoi, Athanassios P. Kyritsis, Vasiliki Galani, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1554-1554
Open Access | Times Cited: 23

Targeting of TAMs: can we be more clever than cancer cells?
Julia Kzhyshkowska, Jiaxin Shen, Irina Larionova
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 12, pp. 1376-1409
Open Access | Times Cited: 9

Sideroflexin family genes were dysregulated and associated with tumor progression in prostate cancers
Hua Huang, Huibo Lian, Wang Liu, et al.
Human Genomics (2025) Vol. 19, Iss. 1
Open Access

LncRNA LINC01128 promotes prostate cancer cell proliferation, metastasis, and epithelial-mesenchymal transition by modulating miR-27b-3p
Yuhui Zhao, Zhigang Zhang, Yi Zheng, et al.
Journal of Cancer Research and Clinical Oncology (2025) Vol. 151, Iss. 3
Open Access

Prostate cancer: Novel genetic and immunologic biomarkers
Mohammad Samare‐Najaf, Hosein Kouchaki, Seyed Moein Mahini, et al.
Clinica Chimica Acta (2024) Vol. 555, pp. 117824-117824
Closed Access | Times Cited: 3

Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer
Maurizio Capuozzo, Mariachiara Santorsola, Monica Ianniello, et al.
Diseases (2024) Vol. 12, Iss. 5, pp. 87-87
Open Access | Times Cited: 3

Epigenetics as a Key Factor in Prostate Cancer
Kadriia Enikeeva, Guzel Rafikova, Yuliya Sharifyanova, et al.
Advanced Biology (2024) Vol. 8, Iss. 5
Closed Access | Times Cited: 2

Aberrant expression of multiple glycolytic enzyme genes is significantly associated with disease progression and survival outcomes in prostate cancers.
Haixia Xu, Wang Liu, Chenchen He, et al.
PubMed (2023) Vol. 11, Iss. 6, pp. 530-541
Closed Access | Times Cited: 5

Mechanism of baicalein in treatment of castration-resistant prostate cancer based on network pharmacology and cell experiments
Baokai Dou, Yingjie Cui, Qianqian Zhou, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

Overexpression of sialyl lewisa carrying mucin-type glycoprotein in prostate cancer cell line contributes to aggressiveness and metastasis
Justen Manasa, Ashwini S. Sanji, Maruti J. Gurav, et al.
International Journal of Biological Macromolecules (2024) Vol. 281, pp. 136519-136519
Closed Access | Times Cited: 1

Splicing variants of versican in CD133+/CD44+ prostate cancer stem cells
Şule Ayla, Emre Karakoc, Yasemin Yozgat Byrne, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155440-155440
Closed Access

In silico and in vitro evaluation of a PE38 and Nb‐based recombinant immunotoxin targeting the GRP78 receptor in cancer cells
Mona Khoshbakht, Mohammad Mahdi Forghanifard, Hossein Aghamollaei, et al.
Biotechnology and Applied Biochemistry (2024)
Open Access

Circulating miRNAs As Biomarkers for Early Disease Diagnosis
Jonas Holdmann, Andreas Savelsbergh, Lukas Markert
Epigenetics and human health (2024), pp. 131-156
Closed Access

Targets for improving prostate tumor response to radiotherapy
Fengguang Li, Yizhi Yu, Ming Jiang, et al.
European Journal of Pharmacology (2024), pp. 177149-177149
Closed Access

Page 1

Scroll to top